skc
Goldmember
- Joined
- 12 August 2008
- Posts
- 8,277
- Reactions
- 329
And here comes the trading update.
FY12 EBITDA = $83-88m so ~good 25% below the guestimates above. US as per expectation, but Oz and EU suffering as expected.
A massive 6-for-7 cap raising at a GFC-type distressed price of $1.02. TERP = $1.46 but hard to see it not trading below that on the open. It "should" stay above $1.02 one would hope.
BBG opened @ $1 and fails to stay above the heavily discounted issue price.
Price now is 94c...
If one is to believe management forecast of EBITDA ~$130m in FY13... the shares at current price are cheap (but we've heard that before!). After the rights issue there'd be ~480m shares on issue, and debt ~$100m. So at 94c, EV ~$550m. EV/EBITDA multiple is only 4.23x... compare that with the Nixon transaction which was done at ~9.2x. So the numbers are there, but the market's trust of BBG hitting forecast is probably non-existence.
Regardless of the fundamentals, there's probably a quick long trade at 94c for price to head back up to $1, with a stop at 92c.